熱門資訊> 正文
Renovaro表示Predictive Oncology终止合并交易
2025-04-04 22:49
- Renovaro BioSciences (NASDAQ:RENB) has announced that it received an email from Predictive Oncology (NASDAQ:POAI) terminating the merger transaction.
- The company added, Renovaro's position is that POI must comply with the binding obligations thereunder and enter into an exclusive License Agreement as required in each of the Binding Agreements.
- Renovaro notes that POI is in breach of the Binding Agreements and has caused substantial damage to Renovaro for which it will seek redress.
- Failure to enter into an exclusive License Agreement on the terms set forth in the Binding Agreement on or before April 10, 2025, will cause Renovaro to seek all its legal remedies to recover all its damages and/or seek additional remedies to fully redress the breaches.
- POAI is -10.2% to $1.23.
- RENB is -10.1% to $0.42.
More on Predictive Oncology, Renovaro Inc., etc.
- Predictive Oncology announces registered direct offering; shares fall
- Predictive Oncology to launch ChemoFx drug response assay in Europe
- Seeking Alpha’s Quant Rating on Predictive Oncology
- Historical earnings data for Predictive Oncology
- Financial information for Predictive Oncology
推薦文章
黃仁勛年內三度訪華！H20重返中國市場，釋放了什麼信號？
美股機會日報 | 6月零售數據高於市場預期；臺積電績后漲超3%
美股「七巨頭」迎特朗普關稅后首次大考！Q2能否交出亮眼成績單，繼續引領美股上漲？
華盛早報丨TACO交易再現！特朗普閃電改口「解僱鮑威爾」；美國眾議院加密貨幣立法進程受阻
財報前瞻 | 特斯拉Q2營收料下滑10%！股價銷量雙殺下，馬斯克能否逆轉局勢？
美股機會日報 | 低於市場預期！美國6月PPI同比增長2.3%；特斯拉官宣Model Y L
華盛早報丨事關中美關税！美財長最新放風；「加密周」突發！多項加密貨幣法案遭眾議院否決
美股機會日報 | 6月CPI符合預期！英偉達盤前漲超4%，今夜有望再創新高
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
